Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 5/20 | 1.00 |
| ▸ | GABBR1 | Q9UBS5 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | DRD3 | P35462 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1052288 | 0.83 | GABBR2 (0.71) | GABBR2GABBR1LMNACYP2C9CYP3A4 | |
| SCHEMBL340904 | 0.80 | GABBR2 (0.67) | GABBR2GABBR1LMNACYP2C9CYP3A4 | |
| SCHEMBL341475 | 0.80 | GABBR2 (0.67) | GABBR2GABBR1LMNACYP2C9CYP3A4 | |
| SCHEMBL27697147 | 0.79 | GABBR2 (0.66) | GABBR2GABBR1LMNACYP2C9CYP3A4 | |
| SCHEMBL9202497 | 0.75 | GABBR2 (0.60) | GABBR2GABBR1LMNACYP2C9CYP3A4 | |
| SCHEMBL4306120 | 0.73 | GABBR2 (0.57) | GABBR2GABBR1LMNACYP2C9CYP3A4 | |
| SCHEMBL27740304 | 0.72 | GABBR2 (0.56) | GABBR2GABBR1LMNACYP2C9CYP3A4 | |
| SCHEMBL341042 | 0.71 | GABBR2 (0.56) | GABBR2GABBR1LMNACYP2C9CYP3A4 | |
| SCHEMBL17459297 | 0.71 | GABBR2 (0.54) | GABBR2GABBR1LMNACYP3A4ADORA3 | |
| Baclofen SCHEMBL5556250 | 0.70 | GABBR2 (1.00) | GABBR2GABBR1LMNACYP2C9CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200182859-A1 | HDAC1/2 ACTIVATOR FOR PROMOTING AND/OR ACCELERATING MYELINATION AND/OR REMYELINATION | UNIVERSITE DE FRIBOURG (CH) | 2020-06-11 | — | — | US | claimed |
| EP-3634421-A1 | HDAC1/2 ACTIVATOR FOR PROMOTING AND/OR ACCELERATING MYELINATION AND/OR REMYELINATION | Université de Fribourg (CH) | 2020-04-15 | — | — | EP | claimed |
| US-20190167632-A1 | METHODS OF TREATING AND PREVENTING/REDUCING THE LIKELIHOOD OF MESIAL TEMPORAL LOBE EPILEPSY (TLE) | MUELLER WOLFGANG S (US) | 2019-06-06 | — | — | US | claimed |
| US-20190125779-A1 | PHARMACEUTICAL COMPOSITIONS | UNIVERSITY OF HOUSTON SYSTEM (US) | 2019-05-02 | — | — | US | claimed |
| US-10238622-B2 | Methods of treating and preventing/reducing the likelihood of Mesial temporal lobe epilepsy (TLE) | THE REGENTS OF THE UNIVERSITY OF NEW MEXICO | 2019-03-26 | — | — | US | claimed |
| WO-2018224650-A1 | HDAC1/2 ACTIVATOR FOR PROMOTING AND/OR ACCELERATING MYELINATION AND/OR REMYELINATION | UNIVERSITE DE FRIBOURG (CH) | 2018-12-13 | — | — | WO | claimed |
| EP-3412294-A1 | HDAC1/2 ACTIVATOR FOR PROMOTING AND/OR ACCELERATING MYELINATION AND/OR REMYELINATION | Universite De Fribourg (CH) | 2018-12-12 | — | — | EP | claimed |
| US-20170042929-A9 | Methods of Treating Neurological Diseases | UNIVERSITY OF HOUSTON | 2017-02-16 | — | — | US | claimed |
| WO-2016109624-A1 | PHARMACEUTICAL COMPOSITIONS | UNIVERSITY OF HOUSTON SYSTEM (US) | 2016-07-07 | — | — | WO | claimed |
| US-20150051166-A1 | Methods of Treating Neurological Diseases | ZIBURKUS JOKUBAS (US) | 2015-02-19 | — | — | US | claimed |
| WO-2004105795-A1 | PHARMACEUTICAL COMBINATIONS OF A PROTON PUMP INHIBITOR AND A COMPOUND WHICH MODIFIES GASTROINTESTINAL MOTILITY | ALTANA PHARMA AG (DE) | 2004-12-09 | — | — | WO | claimed |
| EP-1344524-A1 | Reflux inhibitors | AstraZeneca AB (SE) | 2003-09-17 | — | — | EP | claimed |
| EP-0936906-B1 | REFLUX INHIBITORS | ASTRAZENECA AB (SE) | 2003-09-10 | — | — | EP | claimed |
| US-20030162754-A1 | Use of GABA and GABAB agonists | TUFTS UNIVERSITY | 2003-08-28 | — | — | US | claimed |
| CN-1117560-C | Reflux inhibitors | ASTRA AB (SE) | 2003-08-13 | — | — | CN | claimed |
| US-6117908-A | Use of GABAB receptor agonists as reflux inhibitors | ASTRA AKTIEBOLAG (SE) | 2000-09-12 | — | — | US | claimed |
| WO-1999063935-A2 | RAPID OPIOID DETOXIFICATION THERAPY AND ANTI-READDICTION THERAPY | U.S. DETOX, INC. (US) | 1999-12-16 | — | — | WO | claimed |
| CN-1237105-A | Reflux inhibitors | ASTRA AB (SE) | 1999-12-01 | — | — | CN | claimed |
| EP-0936906-A1 | REFLUX INHIBITORS | Astra Aktiebolag (SE) | 1999-08-25 | — | — | EP | claimed |
| WO-1998011885-A1 | REFLUX INHIBITORS | ASTRA AKTIEBOLAG (SE) | 1998-03-26 | — | — | WO | claimed |